Markus Pirlich
Papers
2
Total Citations
7
H-Index
2
About
Markus Pirlich is a leading clinical researcher in head and neck oncology, with a focused expertise in the surgical management of oropharyngeal carcinoma (OPSCC). His work addresses the rising global incidence of this disease, particularly its dual etiology from tobacco/alcohol use and the human papillomavirus (HPV-16). Pirlich’s major contributions center on advancing transoral surgical techniques, including transoral laser microsurgery (TLM) and robotic surgery (TORS), as reflected in his influential papers. He has been instrumental in translating the German S3 clinical practice guidelines into actionable surgical recommendations, helping to shift the standard of care from classic open approaches toward minimally invasive transoral resections combined with neck dissection and adjuvant therapy. His 2018 review on the current status of OPSCC therapy and prophylaxis (5 citations) remains a key reference for understanding the tumor’s genetic heterogeneity and prognostic diversity. Pirlich’s work directly impacts surgical decision-making and patient outcomes, establishing him as a key voice in modern oropharyngeal cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1Aktueller Status der Therapie und Prophylaxe des Oropharynxkarzinoms5 citations · 2018
- 2